Cyteir Therapeutics, Inc.
NASDAQ:CYT
3.02 (USD) • At close March 15, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 129.242 | 133.635 | 137.204 | 147.12 | 153.89 | 166.396 | 177.383 | 189.723 | 199.822 | 198.637 | 84.195 | 10.938 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 129.242 | 133.635 | 137.204 | 147.12 | 153.89 | 166.396 | 177.383 | 189.723 | 199.822 | 198.637 | 84.195 | 10.938 |
| Net Receivables
| 0 | 0.095 | 0.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -0.017 | -0.095 | -0.252 | 0 | 0 | 0 | 0 | -0.038 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.401 | 0.183 | 1.19 | 2.089 | 3.458 | 3.309 | 3.602 | 3.354 | 4.397 | 1.668 | 1.19 | 1.193 |
| Total Current Assets
| 130.643 | 133.913 | 138.394 | 149.209 | 157.348 | 169.705 | 180.985 | 193.077 | 204.219 | 200.305 | 85.385 | 12.131 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 0.105 | 0.215 | 0.323 | 1.699 | 1.869 | 2.029 | 2.098 | 2.055 | 1.634 | 1.492 | 1.432 | 1.287 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.259 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.261 | 0.26 | 0 | 2.324 | 2.479 | 2.631 | 2.875 | 0.256 | 0.256 | 0.256 | 0.972 | 0.317 |
| Total Non-Current Assets
| 0.366 | 0.475 | 0.582 | 4.023 | 4.348 | 4.66 | 4.973 | 2.311 | 1.89 | 1.748 | 2.404 | 1.604 |
| Total Assets
| 131.009 | 134.388 | 138.976 | 153.232 | 161.696 | 174.365 | 185.958 | 195.388 | 206.109 | 202.053 | 87.789 | 13.735 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 0.508 | 1.339 | 0.674 | 1.128 | 1.666 | 3.613 | 3.509 | 1.785 | 3.276 | 3.512 | 2.805 | 1.689 |
| Short Term Debt
| 0.016 | 0.057 | 0.098 | 0.889 | 0.9 | 0.893 | 0.887 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -0.016 | -0.057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 5.445 | 5.183 | 3.189 | 3.298 | 3.25 | 4 | 4.758 | 5.726 | 4.254 | 3.932 | 1.459 | 1.448 |
| Total Current Liabilities
| 5.969 | 6.579 | 3.961 | 5.315 | 5.816 | 8.506 | 9.154 | 7.511 | 7.53 | 7.444 | 4.264 | 3.137 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.009 | 0.022 | 0.039 | 1.631 | 1.847 | 2.075 | 2.301 | 0.585 | 0.737 | 0.754 | 138.029 | 58.629 |
| Total Non-Current Liabilities
| 0.009 | 0.022 | 0.039 | 1.631 | 1.847 | 2.075 | 2.301 | 0.585 | 0.737 | 0.754 | 138.029 | 58.629 |
| Total Liabilities
| 5.978 | 6.601 | 4 | 6.946 | 7.663 | 10.581 | 11.455 | 8.096 | 8.267 | 8.198 | 142.293 | 61.766 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 161.696 | 174.365 | 185.958 | 0 | 206.109 | 202.053 | 0 | 0 |
| Common Stock
| 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 | 0.034 | 0.002 | 0.002 |
| Retained Earnings
| -162.536 | -159.004 | -150.6 | -138.114 | -129.321 | -118.276 | -106.155 | -92.053 | -80.238 | -68.534 | -57.239 | -49.927 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | -185.958 | 0 | -206.109 | -202.053 | 0 | 0 |
| Other Total Stockholders Equity
| 287.532 | 286.756 | 285.541 | 284.365 | 283.319 | 282.025 | 280.623 | 279.31 | 278.045 | 262.355 | 139.799 | 59.305 |
| Total Shareholders Equity
| 125.031 | 127.787 | 134.976 | 146.286 | 154.033 | 163.784 | 174.503 | 187.292 | 197.842 | 193.855 | -54.504 | -48.031 |
| Total Equity
| 125.031 | 127.787 | 134.976 | 146.286 | 154.033 | 163.784 | 174.503 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 131.009 | 134.388 | 138.976 | 153.232 | 161.696 | 174.365 | 185.958 | 195.388 | 206.109 | 202.053 | 87.789 | 13.735 |